Post-approval studies (Phase 4)Study completedNCT00296296
What this trial is testing
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
Who this might be right for
Kidney TransplantDiabetes Mellitus, Type 2Diabetic Nephropathy
Stanford University 29